Well we all have been guessing for years that partnership must come...looking at risk and rewards for Pharmas with ANP..
I think the Corporate activity may start after the first approval or dosing ..as you say..
Look at Roche....entered into partnership with Sarepta mid way through trials..Also for Pharmas they may want regulatory stuff out of the way before they move in...My call of TO is purely on speculations as to why pay more later ...might as well try now..that's how they would think...
- Forums
- Charts
- Chart
Well we all have been guessing for years that partnership must...
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
-0.003(3.70%) |
Mkt cap ! $82.67M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.8¢ | $215.5K | 2.715M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 137820 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 319232 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 137820 | 0.078 |
4 | 308042 | 0.077 |
4 | 296000 | 0.076 |
6 | 732416 | 0.075 |
2 | 20313 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 319232 | 3 |
0.081 | 188810 | 1 |
0.082 | 183268 | 1 |
0.083 | 37500 | 1 |
0.085 | 225000 | 1 |
Last trade - 15.59pm 19/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |